TBG Diagnostics Ltd - Product Pipeline Analysis, 2023 Update

TBG Diagnostics Ltd - Product Pipeline Analysis, 2023 Update


Summary

TBG Diagnostics Ltd (TBG Diagnostics), formerly Progen Pharmaceuticals Ltd, is a molecular diagnostics company that develops, manufactures and markets molecular diagnostics kits, instruments and services. The company’s major products include COVID-19 testing kits, nucleic acid extraction kits, HLA SBT typing kits, HPA genotyping kits, an automated pipetting system, and gel electrophoresis. It serves clinical laboratories of hospitals and independent reference labs, blood centers, and bone marrow registry labs worldwide. TBG Diagnostics has research and development (R&D) facilities in the US, Taiwan and China and a manufacturing facility in Xiamen, China. The company has collaboration and product licensing agreements with various pharmaceutical companies and others. TBG Diagnostics is headquartered in Melbourne, Victoria, Australia.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company TBG Diagnostics Ltd
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note:Some sections may be missing if data is unavailable for the company"


TBG Diagnostics Ltd Company Overview
TBG Diagnostics Ltd Company Snapshot
TBG Diagnostics Ltd Pipeline Products and Ongoing Clinical Trials Overview
TBG Diagnostics Ltd – Pipeline Analysis Overview
Business Description
TBG Diagnostics Ltd - Key Facts
TBG Diagnostics Ltd - Major Products and Services
TBG Diagnostics Ltd Pipeline Products by Development Stage
TBG Diagnostics Ltd Pipeline Products Overview
Diagnostic Assay - GBS
Diagnostic Assay - GBS Product Overview
Diagnostic Assay - HIV
Diagnostic Assay - HIV Product Overview
Diagnostic Assay - Hospital Acquired Infections
Diagnostic Assay - Hospital Acquired Infections Product Overview
Diagnostic Assay - HPV
Diagnostic Assay - HPV Product Overview
Diagnostic Assay - Quant. HBV
Diagnostic Assay - Quant. HBV Product Overview
Diagnostic Assay - Quant. HCV
Diagnostic Assay - Quant. HCV Product Overview
Diagnostic Assay - STDs
Diagnostic Assay - STDs Product Overview
Diagnostic Assay - Transplantation
Diagnostic Assay - Transplantation Product Overview
Diagnostic Blood Detection Kit - HCV
Diagnostic Blood Detection Kit - HCV Product Overview
Diagnostic Test - Grave's Disease
Diagnostic Test - Grave's Disease Product Overview
ExProbe ABDRDQ
ExProbe ABDRDQ Product Overview
ExProbe ABHPA
ExProbe ABHPA Product Overview
ExProbe B27 Kit
ExProbe B27 Kit Product Overview
Integrated Automated Clinical System
Integrated Automated Clinical System Product Overview
SARS-CoV-2 IgG/IgM Rapid Test Kit
SARS-CoV-2 IgG/IgM Rapid Test Kit Product Overview
TBG Kit - Autoimmune Disease
TBG Kit - Autoimmune Disease Product Overview
TBG Kit - Blood Safety
TBG Kit - Blood Safety Product Overview
TBG Kit - Hereditary Genetic Disease
TBG Kit - Hereditary Genetic Disease Product Overview
TBG Kit - Infectious Disease
TBG Kit - Infectious Disease Product Overview
TBG Kit - Oncology
TBG Kit - Oncology Product Overview
TBG Kit - Transplantation
TBG Kit - Transplantation Product Overview
TBG Diagnostics Ltd - Key Competitors
TBG Diagnostics Ltd - Key Employees
TBG Diagnostics Ltd - Key Employee Biographies
TBG Diagnostics Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
TBG Diagnostics Ltd, Recent Developments
May 28, 2019: TBG Diagnostics: Board changes
Feb 01, 2019: TBG Diagnostics appoints Willy M. Hsu as Chief Operating Officer
Apr 26, 2018: TBG Diagnostics: Director Appointment /Resignation
Oct 23, 2017: TBG Biotechnology First to Receive China FDA Approval for High Resolution HLA Genotyping for Hematopietic Cell Transplantation
Aug 08, 2017: TBG ExProbe Real Time PCR Based Typing Kit receives Taiwan FDA approval and CE Mark, immediately opens markets
Jul 19, 2017: TBG Diagnostics Received ASHI accreditation for Xiamen facility
Nov 17, 2015: TBG Biotechnology (Xiamen) has obtained ISO13485 certification
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Table 1: TBG Diagnostics Ltd Pipeline Products and Ongoing Clinical Trials Overview
Table 2: TBG Diagnostics Ltd Pipeline Products by Equipment Type
Table 3: TBG Diagnostics Ltd Pipeline Products by Indication
Table 4: TBG Diagnostics Ltd, Key Facts
Table 5: TBG Diagnostics Ltd, Major Products and Services
Table 6: TBG Diagnostics Ltd Number of Pipeline Products by Development Stage
Table 7: TBG Diagnostics Ltd Pipeline Products Summary by Development Stage
Table 8: Diagnostic Assay - GBS - Product Status
Table 9: Diagnostic Assay - GBS - Product Description
Table 10: Diagnostic Assay - HIV - Product Status
Table 11: Diagnostic Assay - HIV - Product Description
Table 12: Diagnostic Assay - Hospital Acquired Infections - Product Status
Table 13: Diagnostic Assay - Hospital Acquired Infections - Product Description
Table 14: Diagnostic Assay - HPV - Product Status
Table 15: Diagnostic Assay - HPV - Product Description
Table 16: Diagnostic Assay - Quant. HBV - Product Status
Table 17: Diagnostic Assay - Quant. HBV - Product Description
Table 18: Diagnostic Assay - Quant. HCV - Product Status
Table 19: Diagnostic Assay - Quant. HCV - Product Description
Table 20: Diagnostic Assay - STDs - Product Status
Table 21: Diagnostic Assay - STDs - Product Description
Table 22: Diagnostic Assay - Transplantation - Product Status
Table 23: Diagnostic Assay - Transplantation - Product Description
Table 24: Diagnostic Blood Detection Kit - HCV - Product Status
Table 25: Diagnostic Blood Detection Kit - HCV - Product Description
Table 26: Diagnostic Test - Grave's Disease - Product Status
Table 27: Diagnostic Test - Grave's Disease - Product Description
Table 28: ExProbe ABDRDQ - Product Status
Table 29: ExProbe ABDRDQ - Product Description
Table 30: ExProbe ABHPA - Product Status
Table 31: ExProbe ABHPA - Product Description
Table 32: ExProbe B27 Kit - Product Status
Table 33: ExProbe B27 Kit - Product Description
Table 34: Integrated Automated Clinical System - Product Status
Table 35: Integrated Automated Clinical System - Product Description
Table 36: SARS-CoV-2 IgG/IgM Rapid Test Kit - Product Status
Table 37: SARS-CoV-2 IgG/IgM Rapid Test Kit - Product Description
Table 38: TBG Kit - Autoimmune Disease - Product Status
Table 39: TBG Kit - Autoimmune Disease - Product Description
Table 40: TBG Kit - Blood Safety - Product Status
Table 41: TBG Kit - Blood Safety - Product Description
Table 42: TBG Kit - Hereditary Genetic Disease - Product Status
Table 43: TBG Kit - Hereditary Genetic Disease - Product Description
Table 44: TBG Kit - Infectious Disease - Product Status
Table 45: TBG Kit - Infectious Disease - Product Description
Table 46: TBG Kit - Oncology - Product Status
Table 47: TBG Kit - Oncology - Product Description
Table 48: TBG Kit - Transplantation - Product Status
Table 49: TBG Kit - Transplantation - Product Description
Table 50: TBG Diagnostics Ltd, Key Employees
Table 51: TBG Diagnostics Ltd, Key Employee Biographies
Table 52: TBG Diagnostics Ltd, Subsidiaries
Table 53: Glossary
List of Figures
Figure 1: TBG Diagnostics Ltd Pipeline Products by Equipment Type
Figure 2: TBG Diagnostics Ltd Pipeline Products by Development Stage
"

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings